Literature DB >> 34581461

Correlates of mild, moderate, and severe Alcohol Use Disorder among adults with problem substance use: Validity implications for DSM-5.

Zachary L Mannes1,2, Dvora Shmulewitz2,3, Ofir Livne1,2, Malki Stohl2,3, Deborah S Hasin1,2,3.   

Abstract

BACKGROUND: The DSM-5 definition of alcohol use disorder (AUD) has been well validated, but information is lacking on the extent to which alcohol use, comorbidity, and impairment are associated with the 3 DSM-5-defined AUD severity levels: mild, moderate, and severe. This study examined clinical and functional characteristics as predictors (validators) of these severity levels.
METHODS: Participants aged ≥18 years reporting current problem substance use (N = 588) were recruited between 2016 and 2019 and assessed for DSM-5 AUD and a set of potential validators: indicators of alcohol use severity (i.e., craving, binge drinking frequency, problematic use, and harmful drinking), psychiatric disorders, and functional impairment. Multinomial logistic regression models examined the association between the predictors and the 3 AUD severity levels (mild, moderate, and severe) vs the reference group, no AUD, controlling for sociodemographic characteristics and other substance use.
RESULTS: All alcohol use validators were associated with a greater likelihood of all 3 AUD severity levels compared with the no-AUD group. However, psychiatric disorders were associated only with severe AUD and participants with major depression (aOR = 2.44), posttraumatic stress disorder (aOR = 1.65), borderline personality disorder (aOR = 1.99), and antisocial personality disorder (aOR = 1.78) had a greater likelihood of severe AUD than the no-AUD group. Functioning validators were also associated only with severe AUD and participants with social (aOR = 1.87), physical (aOR = 1.62), or mental (aOR = 1.84) impairment had a greater likelihood of severe AUD than the no-AUD group. Many alcohol-related, psychiatric, and functioning validators were associated with greater odds of severe AUD than mild or moderate AUD.
CONCLUSION: This study supports the criterion validity of the DSM-5 tri-categorical measure of AUD. Specifically, results fully supported the validity of severe AUD by its associations with all predictors, whereas the validity of mild and moderate AUD was supported only by alcohol use predictor variables. Findings suggest the value of using severity-specific interventions utilizing the DSM-5 AUD.
© 2021 by the Research Society on Alcoholism.

Entities:  

Keywords:  AUD; alcohol use; alcohol use disorder; functional impairment; mental health

Mesh:

Year:  2021        PMID: 34581461      PMCID: PMC8602758          DOI: 10.1111/acer.14701

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.928


  73 in total

1.  Dimensionality and stages of severity of DSM-5 criteria in an international sample of alcohol-consuming individuals.

Authors:  U W Preuss; S Watzke; F M Wurst
Journal:  Psychol Med       Date:  2014-04-25       Impact factor: 7.723

2.  The effectiveness of residential treatment services for individuals with substance use disorders: A systematic review.

Authors:  Dominique de Andrade; Rachel A Elphinston; Catherine Quinn; Julaine Allan; Leanne Hides
Journal:  Drug Alcohol Depend       Date:  2019-06-20       Impact factor: 4.492

3.  The role of alcohol use and drinking patterns in socioeconomic inequalities in mortality: a systematic review.

Authors:  Charlotte Probst; Carolin Kilian; Sherald Sanchez; Shannon Lange; Jürgen Rehm
Journal:  Lancet Public Health       Date:  2020-06

4.  Comparison of categorical alcohol dependence versus a dimensional measure for predicting weekly alcohol use in heavy drinkers.

Authors:  Tera L Fazzino; Gail L Rose; Keith B Burt; John E Helzer
Journal:  Drug Alcohol Depend       Date:  2014-01-14       Impact factor: 4.492

5.  Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population.

Authors:  Deborah S Hasin; Melanie Wall; Katie Witkiewitz; Henry R Kranzler; Daniel Falk; Raye Litten; Karl Mann; Stephanie S O'Malley; Jennifer Scodes; Rebecca L Robinson; Raymond Anton
Journal:  Lancet Psychiatry       Date:  2017-04-26       Impact factor: 27.083

6.  The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample.

Authors:  Deborah S Hasin; Eliana Greenstein; Christina Aivadyan; Malki Stohl; Efrat Aharonovich; Tulshi Saha; Rise Goldstein; Edward V Nunes; Jeesun Jung; Haitao Zhang; Bridget F Grant
Journal:  Drug Alcohol Depend       Date:  2014-12-18       Impact factor: 4.492

7.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.

Authors:  J B Saunders; O G Aasland; T F Babor; J R de la Fuente; M Grant
Journal:  Addiction       Date:  1993-06       Impact factor: 6.526

8.  A test of the DSM-5 severity scale for alcohol use disorder.

Authors:  Tera L Fazzino; Gail L Rose; Keith B Burt; John E Helzer
Journal:  Drug Alcohol Depend       Date:  2014-05-17       Impact factor: 4.492

Review 9.  The relationship between different dimensions of alcohol use and the burden of disease-an update.

Authors:  Jürgen Rehm; Gerhard E Gmel; Gerrit Gmel; Omer S M Hasan; Sameer Imtiaz; Svetlana Popova; Charlotte Probst; Michael Roerecke; Robin Room; Andriy V Samokhvalov; Kevin D Shield; Paul A Shuper
Journal:  Addiction       Date:  2017-02-20       Impact factor: 6.526

Review 10.  Advances in the science and treatment of alcohol use disorder.

Authors:  K Witkiewitz; R Z Litten; L Leggio
Journal:  Sci Adv       Date:  2019-09-25       Impact factor: 14.136

View more
  1 in total

1.  Validity of the DSM-5 tobacco use disorder diagnostics in adults with problematic substance use.

Authors:  Dvora Shmulewitz; Eliana Greenstein; Malka Stohl; David S Fink; Stephanie Roncone; Claire Walsh; Efrat Aharonovich; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2022-03-17       Impact factor: 4.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.